MedPath

Effect of Single Dose Antenatal Betamethasone on Neonatal Respiratory Morbidity After Elective Cesarean

Not Applicable
Conditions
Respiratory Morbidity
Registration Number
NCT04407975
Lead Sponsor
Makassed General Hospital
Brief Summary

Patients undergoing elective C-section will be randomized into two groups. The first group will receive one dose of Betamethasone at least 24 hours before scheduled C-section. The second group will receive placebo.

Detailed Description

This is a prospective double blinded randomized clinical trial. Patients will be randomized into two groups. Group A will receive one dose of Betamethasone at least 24 hours before scheduled C-section. Group B will receive placebo. The maternal and neonatal outcomes will be studied in order to assess the effect of Betamethasone on respiratory morbidity of the newborn infant.

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
400
Inclusion Criteria
  • women with singleton or multiple gestation,
  • between 37 and 40 weeks of pregnancy (as calculated from the first day of the last menstrual period)
Exclusion Criteria
  • any medical problem that could affect fetal well-being;
  • evidence of intrauterine infection,
  • oligohydramnios,
  • fetal congenital malformations,
  • preeclampsia,
  • maternal hypertension,
  • severe fetal rhesus sensitization,
  • antepartum hemorrhage,
  • Intrauterine growth restriction
  • preterm rupture of membranes
  • preterm delivery
  • previously received antenatal steroids less than one month ago
  • those who decline to participate in the study.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Percentage of patients with respiratory morbidityat birth

Neonatal respiratory morbidity will be assessed through oxygen saturation, Apgar score and Silverman score

Secondary Outcome Measures
NameTimeMethod
Admission to Neonatal Intensive Care Unit (NICU)up to 2 weeks

Reasons for NICU admission and length of stay

Trial Locations

Locations (1)

Makassed General Hospital

🇱🇧

Beirut, Lebanon

Makassed General Hospital
🇱🇧Beirut, Lebanon
Manal Hubesih, MD
Contact
+9611636000
drmanalhubesihhusari@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.